MedPath

Laser-assisted ICSI Versus Conventional ICSI

Not Applicable
Completed
Conditions
Infertility
Registration Number
NCT03665103
Lead Sponsor
Ibn Sina Hospital
Brief Summary

Degeneration rate after ICSI is expectable but decreasing it is a goal. Laser-assisted ICSI can serve to decrease this degeneration rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
966
Inclusion Criteria
  • all ICSI cycles
Exclusion Criteria
  • no exclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
oocyte survival after injection6 days of culture
Secondary Outcome Measures
NameTimeMethod
ongoing pregnancy rateTwelve weeks of gestation
blastocyst formation rate6 days of culture
embryo utilization rate6 days of culture
clinical pregnancy ratefour weeks after embryo transfer

Trial Locations

Locations (1)

IbnSina IVF Center

🇪🇬

Sohag, Egypt

IbnSina IVF Center
🇪🇬Sohag, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.